Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.01
-0.30 (-3.22%)
At close: Jul 31, 2026, 4:00 PM EDT
9.17
+0.16 (1.78%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Kura Oncology Employees
Kura Oncology had 260 employees as of December 31, 2025. The number of employees increased by 68 or 35.42% compared to the previous year.
Employees
260
Change (1Y)
68
Growth (1Y)
35.42%
Revenue / Employee
$275,535
Profits / Employee
-$1,132,962
Market Cap
799.86M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Geron | 258 |
| Omeros | 175 |
| DBV Technologies | 170 |
| Solid Biosciences | 121 |
| Aura Biosciences | 113 |
| Odyssey Therapeutics | 100 |
| Annexon | 93 |
| Theravance Biopharma | 90 |
KURA News
- 5 days ago - Kura Oncology Transcript: Study update - Transcripts
- 5 days ago - Kura Oncology Press release: Study update - Filings
- 5 days ago - Kura Oncology Slides: Study update - Filings
- 5 days ago - Kura Oncology announces durable activity of darlifarnib combination in ccRCC - TheFly
- 5 days ago - Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026 - GlobeNewsWire
- 18 days ago - Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib's Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026 - GlobeNewsWire
- 4 weeks ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Kura Oncology Transcript: Status update - Transcripts